Concepedia

Y. Panaseykin

YP

2

Publications

94

Citations

2

H-Index

2020

Active since

Affiliations

Harbor–UCLA Medical Center(Current)

Providence Portland Medical Center

Medical Radiological Research Center

Russian Cancer Research Center NN Blokhin

Princess Margaret Cancer Centre

Y. Panaseykin is an author at Harbor–UCLA Medical Center specializing in radiation oncology, pharmacotherapy, and cancer therapeutics.

Top concepts

MedicineOncologyPharmacologyCancer TherapyThyroid CancerCancer ResearchPharmacotherapyNuclear MedicineRadiation Oncology

Publications per year

2020–2021

2

Publications

2

A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer

Marcia S. Brose, Y. Panaseykin, Bhavana Konda et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 81 citations · Full text

426P A multicenter, randomized, double-blind, phase II study of lenvatinib (LEN) in patients (pts) with radioiodine-refractory differentiated thyroid cancer (RR-DTC) to evaluate the safety and efficacy of a daily oral starting dose of 18 mg vs 24 mg

Marcia S. Brose, Y. Panaseykin, Bhavana Konda et al. · Annals of Oncology · 2020 · 13 citations

Nuclear Medicine, Oncology, Medicine +11

Rows per page

1–2 of 2